Navigation Links
Multiple Dose Clinical Trial of TorreyPines Therapeutics' Tezampanel Demonstrates Compound is Safe and Well-Tolerated
Date:2/5/2008

will be established, or if established, will remain the same, be better or worse in future clinical trials, if any; whether pre-clinical results will be substantiated by ongoing or future clinical trials, if any, or whether any of its product candidates will be able to improve the signs or symptoms of their respective clinical indication; whether any of its product candidates will support an NDA filing, will be approved by the FDA or its equivalent, or if approved, will prove competitive in the market; or whether the necessary financing to support its drug development programs will be available. Actual results may differ materially from the above forward-looking statements due to a number of other important factors. These and other risks which may impact management's expectations are described in greater detail in the TorreyPines Therapeutics annual report on Form 10-K for the year ended Dec. 31, 2006, as well as TorreyPines Therapeutics' subsequent filings with the Securities and Exchange Commission. TorreyPines Therapeutics undertakes no obligation to publicly release the result of any revisions to such forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

Company Contact:

Ev Graham

TorreyPines Therapeutics, Inc.

858-623-5665, x118

graham@torreypinestherapeutics.com

Media Contact:

David Schull

Russo Partners, LLC

212-845-4271

david.schull@russopartnersllc.com

Investor Contact:

Rhonda Chiger

Rx Communications

917-322-2569

rchiger@rxir.com

Investor Contact:

John Baldissera

BPC Financial Marketing

800-368-1217


'/>"/>
SOURCE TorreyPines Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Genomic Health Announces Identification of Genes Associated With Colon Cancer Recurrence Across Multiple Studies
2. Thalidomide Pharmion(R) Receives Positive Opinion for Treatment of First-line Multiple Myeloma from European Medicines Agency
3. Multiple Studies Presented at San Antonio Breast Cancer Symposium Reinforce Clinical Utility of Oncotype DX(R)
4. Study of Pathwork Diagnostics Tissue of Origin Test Published in the Journal of Molecular Diagnostics: Investigates Test Reproducibility in Multiple Labs to Determine Primary Tumor in Cancer Cases
5. Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology
6. Kosan Presents Updated Data on Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma at Ash
7. Pharmacopeia Announces Additional Positive Findings from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
8. New Data to Support VELCADE(R) (Bortezomib) For Injection Based Therapies as Setting New Standards in The Care of Newly Diagnosed Patients With Multiple Myeloma
9. Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE(R) (Irbesartan-Hydrochlorothiazide) as the First Combination Therapy for Initial Use in Patients Likely to Need Multiple Drugs to Achieve Their Blood
10. Conatus Pharmaceuticals Reports Positive Results of CTS-1027 in Multiple Preclinical Studies of Liver Disease
11. Studies Attribute Recent Increase in Multiple Myeloma Survival to Novel Therapies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... the leading health care supply chain expertise, analytics and ... national contracts that expand its portfolio to provide hospital ... These include manufacturer product and service agreements, as well ... IT consulting support. New Novation agreements ...
(Date:1/15/2014)... FORT WORTH, Texas , Jan. 15, 2014  Humberto ... in Dermatology Achievement Award" from the Journal of ... Dermatology Aesthetic & Clinical Conference (ODAC). The event is January ... Florida . The ...
(Date:1/15/2014)... , Jan. 15, 2014 Tegra Medical is very ... King as its new Chief Executive Officer.  Mark was ... which he has overseen the company,s four facilities in ... Costa Rica.  Mr. King joined Tegra Medical in 2012 with ...
Breaking Medicine Technology:New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3
... Medical Corporation has provided an educational grant to establish ... .  "Atrium has been proud to be the market ... McGill, Senior Vice President of Marketing and Corporate Communications. ... nurses and physicians, we decided to emphasize our commitment ...
... 15, 2011 Johnson & Johnson (NYSE: ... agreement with Merck regarding distribution rights for REMICADE® (infliximab) ... The amended agreement announced today in a separate news ... had been filed by Johnson & Johnson in May ...
Cached Medicine Technology:Atrium Provides Grant to Establish Education Web Site at AtriumU.com 2Johnson & Johnson Provides Additional Information Regarding Amended Agreement With Merck 2Johnson & Johnson Provides Additional Information Regarding Amended Agreement With Merck 3
(Date:7/10/2014)... News) -- Adults with dyslexia are more likely to ... teenagers than people who don,t have the learning disorder, ... affects up to 10 percent of people, causes problems ... of adults with this condition said they suffered physical ... those without dyslexia. "Even after accounting for age, ...
(Date:7/10/2014)... Dennis Thompson HealthDay ... Forget about the Twitter wars that break out regularly between ... be bad for your own relationship, a new study suggests. ... within a couple, even if the couple is in a ... 581 Twitter users. In turn, that friction can lead ...
(Date:7/10/2014)... who research issues ranging from child abuse to urban ... the International Society for Research on Aggression (ISRA) at ... University is hosting the prestigious world meeting, which is ... are excited to be bringing together leading scholars from ... fresh ideas about the causes, consequences and solutions to ...
(Date:7/10/2014)... known as the "Mississippi baby" an infant seemingly cured ... a prolonged remission of HIV infection in The New ... of HIV after more than two years of not taking ... HIV specialist and researchers involved in the case. ... this young child, the medical staff involved in the child,s ...
(Date:7/10/2014)... medical imaging far outweigh the risks when children receive ... Right Radiation Dose. However, overuse and misuse of imaging ... a collaborative effort to ensure a national protocol is ... Journal of Patient Safety , calls for the ... Accreditation Commission, and the Centers for Medicare & Medicaid ...
Breaking Medicine News(10 mins):Health News:Researchers See Link Between Dyslexia, Abuse 2Health News:Are You Tweeting Your Marriage Away? 2Health News:Are You Tweeting Your Marriage Away? 3Health News:Georgia State hosts national conference on aggression 2Health News:Georgia State hosts national conference on aggression 3Health News:'Mississippi Baby' now has detectable HIV, researchers find 2Health News:'Mississippi Baby' now has detectable HIV, researchers find 3Health News:Mayo Clinic calls for standardization of safe imaging protocols for children 2
... records and embedded tools can alert and direct pediatricians ... and teenagers, according to a new Kaiser Permanente study ... Researchers analyzed visits for nearly 740,000 children and ... of computer-assisted decision tools and found that extracting information ...
... News) -- Researchers who traced the evolution of a ... livestock to humans say their findings highlight the dangers ... The international team of scientists studied methicillin-resistant Staphylococcus ... livestock-associated MRSA, which most often infects people with direct ...
... you use your right hand to hold your cell phone up to ... in Detroit. The study finds a strong correlation between brain dominance ... than 70 percent of participants holding their cell phone up to the ... brain dominate people those whose speech and language center is on ...
... 2012 A simple blood test is being developed by ... University Medical Center in Beer-Sheva, Israel that may provide early ... BGU,s Faculty of Health Sciences and his team developed a ... of blood. The test uses infrared light to detect miniscule ...
... have discovered that cancer-causing genetic mutations have better-disguised electronic signatures ... them fly under the radar of the body,s defence mechanisms. ... University of Warwick and in Taiwan hint at the possibility ... a role in early diagnosis and detection of mutation hotspots. ...
... within each cell that regulate metabolism and energy use, ... according to a new study. Manipulation of two biochemical ... could shrink human lung cancers transplanted into mice, a ... FASEB . Within each cell, mitochondria are constantly ...
Cached Medicine News:Health News:Computer-assisted tools alert pediatricians to obese patients 2Health News:Computer-assisted tools alert pediatricians to obese patients 3Health News:Pig-to-Human 'Superbug' May Be Due to Animal Antibiotics 2Health News:Study: Brain makes call on which ear is used for cell phone 2Health News:Study: Brain makes call on which ear is used for cell phone 3Health News:'Stealth' properties of cancer-causing genetic mutations identified 2Health News:Energy network within cells may be new target for cancer therapy 2Health News:Energy network within cells may be new target for cancer therapy 3
MDI will work with your facility to determine the best interim lab to fit your needs and your site....
... 300 ,Oblique 45, ,Type 330 ,Straight, ... by setting the illumination between lenses ... ideal for use in ophthalmology and ... conventional compact microscope can; an advanced ...
... same as the model SP-8800 with one big exception. ... This mode has its own fixation targets to allow ... allows you to select an area on the cornea ... to calculate averages of multiple readings in any one ...
... MedCath is the largest and most experienced ... networks in the United States. Mobile laboratories ... a daily basis, from one hospital to ... geographic area. Each mobile laboratory is fully ...
Medicine Products: